Annals of Medicine is an online, open access, international journal publishing across 33 areas of medicine and is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team, with guaranteed response times of within 48 hours.

The journal promotes collaboration across therapy areas and the open sharing of research. Combined with its scope covering translational medicine to clinical practice, Annals of Medicine is the home for researchers dedicated to supporting medical professionals in advancing practice for patients worldwide.

Accepting original research articles, review articles, clinical trials, protocols, case series and commentaries, the journal welcomes the submission of negative and null results, and reproducibility studies. Letters to the Editor are also considered and should discuss an analysis of an article previously published in Annals of Medicine.

Case reports are not accepted. Case series must review a minimum of 5 cases and will be considered where they provide novel insight on a disease or disease subtype.

When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors' own data through replication in an original sample. Consideration of studies utilizing publicly available data is at the discretion of the Editor.

Pharmacological studies based solely on in silico analyses without experimental validation are not considered.

Bibliometric analyses and scoping reviews are not considered. 

The journal welcomes submissions to the following sections:

    Addiction
    Anesthesiology
    Cardiology & Cardiovascular Disorders
    Clinical Pathology
    Dermatology
    Emergency Medicine
    Endocrinology
    Gastroenterology
    Geriatrics
    Hematology
    Hepatology
    Immunology
    Infectious Diseases
    Medical Education
    Medical Genetics & Genomics
    Nephrology
    Neurology
    Nutrition
    Oncology
    Ophthalmology
    Pediatrics
    Pharmacology
    Pregnancy, Childbirth & Women's Health
    Primary Care
    Psychiatry
    Public Health
    Pulmonary Medicine
    Physical Medicine & Rehabilitation
    Rheumatology
    Sports Medicine & Musculoskeletal Disorders
    Surgery
    Toxicology
    Urology

Peer review statement
All submitted manuscripts are subject to initial appraisal by the Editorial Team and, if found suitable for further consideration, to single anonymized peer review by independent, expert referees.

According to the STM definitions and terminology for peer review practices, the following summary describes the peer review processes for this journal: 

Standard Submissions to the journal - Single Anonymized Peer Review

Identity transparency: single anonymized

Reviewer interacts with: Editor

Review information published: None

Post publication commenting: None


Submission included in the ChinaXiv/biomedRxiv Open Review Pilot – Open Peer Review

Submissions which are included in the ChinaXiv/biomedRxiv Open Review pilot will be subject to initial appraisal by the Editorial team and, if found suitable for consideration, to open peer review by independent, expert referees. Under this open peer review pilot model:

    All identities are visible to each other (Decision-making Editor, Reviewer, Author);
    Reviewer and Author interacts with Decision-making Editor only;
    All reviewer reports are published on ChinaXiv/biomedRxiv;
    All submitted manuscripts and revised versions are published on ChinaXiv/biomedRxiv;
    Editor communication with Author (e.g., Editor decision letter) are also published on ChinaXiv/biomedRxiv;
    Manuscripts which have been peer reviewed and accepted will be published in Annals of Medicine.

Identity transparency: all identities visible

Reviewer interacts with: Editor

Review information published: Review reports, Submitted manuscript, Reviewer identities, Author/Editor communication, Editor identities (all published on ChinaXiv/biomedRxiv platform)

Post publication commenting: None